blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2081938

EP2081938 - SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO Ý1,2-A PIRIMIDIN-6-ONE AND 8-PIPERIDINYL-2-PYRIMIDI NYL-PYRIMIDOÝ1,2,-A PYRIMIDIN-6-ONE DERIVATIVES [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  28.12.2012
Database last updated on 03.10.2024
Most recent event   Tooltip28.12.2012Withdrawal of applicationpublished on 30.01.2013  [2013/05]
Applicant(s)For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-shi
Osaka 541-8505 / JP
[N/P]
Former [2012/18]For all designated states
SANOFI
54 rue La Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-shi
Osaka 541-8505 / JP
Former [2012/17]For all designated states
SANOFI
54, rue de la Boétie
75008 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-shi
Osaka 541-8505 / JP
Former [2011/30]For all designated states
SANOFI
174, Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-Shi
Osaka 541-8505 / JP
Former [2010/01]For all designated states
Sanofi-Aventis
174 Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18 Kitahama, Chuo-Ku Osaka-Shi
Osaka 541-8505 / JP
Former [2009/31]For all designated states
Sanofi-Aventis
174 Avenue de France
75013 Paris / FR
For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Inventor(s)01 / LOCHEAD, Alistair
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
02 / SAADY, Mourad
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
03 / SLOWINSKI, Franck
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
04 / YAICHE, Philippe
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
 [2009/31]
Representative(s)Morel-Pécheux, Muriel, et al
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
[N/P]
Former [2009/31]Morel-Pécheux, Muriel, et al
Sanofi-Aventis Département Brevets 174 avenue de France
75013 Paris / FR
Application number, filing date07859310.006.11.2007
[2009/31]
WO2007IB04272
Priority number, dateEP2006029172507.11.2006         Original published format: EP 06291725
[2009/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008056266
Date:15.05.2008
Language:EN
[2008/20]
Type: A2 Application without search report 
No.:EP2081938
Date:29.07.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 15.05.2008 takes the place of the publication of the European patent application.
[2009/31]
Search report(s)International search report - published on:EP10.07.2008
ClassificationIPC:C07D487/04, A61K31/519, A61P25/28, A61P35/00, A61P33/06, A61P37/00
[2009/31]
CPC:
C07D487/04 (EP,KR,US); A61K31/519 (KR); A61P1/16 (EP);
A61P17/02 (EP); A61P17/14 (EP); A61P19/00 (EP);
A61P19/08 (EP); A61P25/00 (EP); A61P25/02 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P33/06 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/00 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P9/00 (EP); C07D487/02 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/31]
Extension statesAL08.06.2009
BA08.06.2009
HR08.06.2009
MK08.06.2009
RS08.06.2009
TitleGerman:SUBSTITUIERTE 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO [1,2-A]PIRIMIDIN-6-ON- UND 8-PIPERIDINYL-2-PYRIMIDI NYL-PYRIMIDO[1,2,-A]PYRIMIDIN-6-ON-DERIVATIVE[2009/31]
English:SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO Ý1,2-A PIRIMIDIN-6-ONE AND 8-PIPERIDINYL-2-PYRIMIDI NYL-PYRIMIDOÝ1,2,-A PYRIMIDIN-6-ONE DERIVATIVES[2009/31]
French:8-PIPÉRIDINYL-2-PYRIDINYLPYRIMIDOÝ1,2-A PIRIMIDIN-6-ONE SUBSTITUÉE ET DÉRIVÉS DE 8-PIPÉRIDINYL-2-PYRIMIDINYLPYRIMIDOÝ1,2-A PYRIMIDIN-6-ONE[2009/31]
Entry into regional phase08.06.2009National basic fee paid 
08.06.2009Designation fee(s) paid 
08.06.2009Examination fee paid 
Examination procedure08.06.2009Examination requested  [2009/31]
21.12.2012Application withdrawn by applicant  [2013/05]
Fees paidRenewal fee
12.11.2009Renewal fee patent year 03
12.11.2010Renewal fee patent year 04
14.11.2011Renewal fee patent year 05
13.11.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2005000800  (MERCK FROSST CANADA INC [CA], et al) [A] 1-16 * page 3, formula I * * page 12, lines 25-27 * * page 15, line 7 ** page 16, lines 7,27 *;
 [A]EP1557417  (SANOFI AVENTIS [FR], et al) [A] 1-12 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.